Wird geladen...

One year of complete clinical response in a metastatic breast cancer patient treated with a combination of lapatinib and gemcitabine

The treatment of metastatic breast cancer is challenging. We recently assisted in the development of targeted therapies (in combination with chemotherapy or as monotherapy) that have improved results for selected groups of patients. Lapatinib is a dual tyrosine kinase inhibitor that has shown effica...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Gasent Blesa, J.M., Laforga Canales, J., Candel‡, V. Alberola
Format: Artigo
Sprache:Inglês
Veröffentlicht: Multimed Inc. 2010
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2854642/
https://ncbi.nlm.nih.gov/pubmed/20404981
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!